QURE uniQure NV

uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today announced that its management will present at the Jefferies 2015 Global Healthcare Conference – London, to be held November 18-19, 2015.

Date: November 19, 2015

Time: 4:00 p.m. (GMT)

Speaking for uniQure: Jörn Aldag, Chief Executive Officer

To access a simultaneous webcast of Mr. Aldag's presentation via the internet, log on to the "Events" section on the Media page of the uniQure website at http://www.uniqure.com/news/calendar-of-events/.

A replay of the webcast will be available from uniQure's website for 30 days following the conference. Mr. Aldag's presentation will be available for download in PDF format immediately following the conference presentation in the "Events" section of the Media page of uniQure's website at http://www.uniqure.com/news/calendar-of-events/.

About uniQure

uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with CNS, liver/metabolic and cardiovascular diseases. www.uniQure.com

CONTACT: uniQure:
         Aicha Diba
         Investor Relations
         Direct : +31 20 240 6100
         Main: +31 20 566 7394
         a.diba@uniQure.com
         
         Media inquiries:
         Gretchen Schweitzer
         MacDougall Biomedical Communications
         Direct: +49 172 861 8540
         Main: +49 89 2424 3494 or +1 781 235 3060
         gschweitzer@macbiocom.com